Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-0807-2021Class II

VERITAS Collagen Matrix -

Baxter Healthcare Corporation / initiated 2020-12-11 / Terminated / root cause: manufacturing process

Baxter Healthcare Corporation began a recall of VERITAS Collagen Matrix - Product Usage: intended for use in reconstruction of the pelvic floor excluding transvaginal pelvic organ prolapse and for use in the... on . FDA classified it as Class II and gives the reason as "VERITAS Collagen Matrix 12x25 cm Patches may have undersized width dimensions". As of , the recall status on record is Terminated, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-0807-2021
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Baxter Healthcare Corporation
Product
VERITAS Collagen Matrix - Product Usage: intended for use in reconstruction of the pelvic floor excluding transvaginal pelvic organ prolapse and for use in the repair of rectal prolapse excluding rectocele.
Product code
FTM Mesh, Surgical
Reason for recall
VERITAS Collagen Matrix 12x25 cm Patches may have undersized width dimensions.
Root cause tag
manufacturing process
FDA root cause
Process design
Action
An Urgent Medical Device Recall communication, FA-2020-057, will be sent to all affected customers via U.S.P.S., first class mail.
Quantity in commerce
192 units
Distribution
Worldwide distribution - US Nationwide distribution including in the states of FL, IL, MA, MS, OH, OR, TX, VA, WA, WV and the countries of Australia, Poland, and United Kingdom.
Product codes and lots
Product Code: RM1225BIO, RM1225; GTIN: 00085412531274; Lot Number/Expiration Date: SP20A15-1421512/ 10/8/2022,  SP20F22-1459746/ 4/1/2023.  SP20I03-1474281/ 6/30/2023, SP19K25-1412935/ 7/1/2022, SP19K25-1412937/ 7/1/2022,  SP19L09-1415842/ 10/8/2022,  SP20A16-1421898/ 10/8/2022,  SP20B18-1429818/ 1/2/2023,  SP20B20-1430375/ 1/2/2023, SP20C27-1439804/ 2/11/2023, SP20C27-1439818/ 2/11/2023,  SP20D01-1440793/ 2/25/2023,  SP20D28-1447333/ 2/25/2023, SP20E28-1454035/ 4/1/2023,  SP20G08-1462458/ 4/30/2023,  SP20G14-1463550/ 4/30/2023,  SP20G14-1463605/ 4/30/2023,  SP20G21-1465131/ 6/2/2023,  SP20G14-1463552/ 6/2/2023,  SP20I08-1474874/ 6/30/2023,  SP20I08-1474885/ 8/5/2023,  SP20I08-1474895/ 8/5/2023

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-0807-2021
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-0807-2021Class IITerminatedVoluntary: Firm initiated